UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Carcinoma with Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy Regimens

Clinical cancer research, 2008-03, Vol.14 (5), p.1296-1302

2008

Volltextzugriff (PDF)

Continuing Reassessment of the Risks of Erythropoiesis-Stimulating Agents in Patients with Cancer

Clinical cancer research, 2008-06, Vol.14 (11), p.3242-3247

2008

Volltextzugriff (PDF)

Good Clinical Practice and the Conduct of Clinical Studies in Pediatric Oncology

The Pediatric clinics of North America, 2008-02, Vol.55 (1), p.187-209

2008

Volltextzugriff (PDF)

Prevention of surgical-site infections

The New England journal of medicine, 2010-04, Vol.362 (16), p.1541-2; author reply 1543-4

2010

Volltextzugriff (PDF)

Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis

Pediatrics (Evanston), 2004-01, Vol.113 (1 Pt 1), p.134-134

Weiss, Karen D

2004

Volltextzugriff (PDF)

Judging the safety of aprotinin

The New England journal of medicine, 2006-11, Vol.355 (21), p.2262

2006

Volltextzugriff (PDF)

011. Best practices of safe NSAID use: A systematic review of the literature

European journal of pain supplements, 2011-11, Vol.5 (2), p.511-511

2011

Volltextzugriff (PDF)

Changes in trial parameters

The Lancet (British edition), 2001-01, Vol.357 (9252), p.314-314

2001

Volltextzugriff (PDF)

Judging the Safety of Aprotinin

The New England journal of medicine, 2006-11, Vol.355 (21), p.2261-2262

2006

Volltextzugriff (PDF)

Riposte: FDA response to ‘Yin, yang and the biopharmaceutical industry’

Journal of commercial biotechnology, 2003-09, Vol.10 (1), p.36-39

2003

Volltextzugriff (PDF)

Prevention of Surgical-Site Infections

The New England journal of medicine, 2010-04, Vol.362 (16), p.1540-1544

Anderson, Deverick J

2010

Volltextzugriff (PDF)

Boxed Warnings and Other FDA Communication Tools

American family physician, 2010-02, Vol.81 (3), p.259-260

2010

Volltextzugriff (PDF)

Relationship between 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas

Biochemical pharmacology, 1986-04, Vol.35 (8), p.1351-1358

1986

Volltextzugriff (PDF)

Chapter 21 - Testing of Adenoviral Vector Gene Transfer Products: FDA Expectations

Adenoviral Vectors for Gene Therapy, 2003, p.615-654

2003

Volltextzugriff (PDF)

Regulatory issues in clinical applications of cytokines and growth factors

Progress in growth factor research, 1994, Vol.5 (2), p.213-222

1994

Volltextzugriff (PDF)

Riposte: FDA response to 'Yin, yang and the biopharmaceutical industry'

Journal of commercial biotechnology, 1969-12, Vol.10 (1)

1969

Volltextzugriff (PDF)

State and Local Chronic Disease Surveillance Using Electronic Health Record Systems

American journal of public health (1971), 2017-09, Vol.107 (9), p.1406-1412

2017

Volltextzugriff (PDF)

Mouse screen reveals multiple new genes underlying mouse and human hearing loss

PLoS biology, 2019-04, Vol.17 (4), p.e3000194-e3000194

2019

Volltextzugriff (PDF)

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2020-04, Vol.158 (5), p.1450-1461

2020

Volltextzugriff (PDF)

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4148-4154

2012

Volltextzugriff (PDF)

AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2021-06, Vol.160 (7), p.2496-2508

2021

Volltextzugriff (PDF)

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

The New England journal of medicine, 2015-09, Vol.373 (11), p.1040-1047

2015

Volltextzugriff (PDF)

Cryopyrin activates the inflammasome in response to toxins and ATP

Nature, 2006-03, Vol.440 (7081), p.228-232

2006

Volltextzugriff (PDF)

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3210-3218

2001

Volltextzugriff (PDF)

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

The Journal of clinical investigation, 2019-06, Vol.129 (6), p.2210-2221

2019

Volltextzugriff (PDF)

1 – 25 von 350

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(294)

Publikationsform

Sprache

Englisch
(349)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Carcinoma with Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy Regimens

Continuing Reassessment of the Risks of Erythropoiesis-Stimulating Agents in Patients with Cancer

Good Clinical Practice and the Conduct of Clinical Studies in Pediatric Oncology

Prevention of surgical-site infections

Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis

Judging the safety of aprotinin

011. Best practices of safe NSAID use: A systematic review of the literature

Changes in trial parameters

Judging the Safety of Aprotinin

Riposte: FDA response to ‘Yin, yang and the biopharmaceutical industry’

Prevention of Surgical-Site Infections

Boxed Warnings and Other FDA Communication Tools

Relationship between 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas

Chapter 21 - Testing of Adenoviral Vector Gene Transfer Products: FDA Expectations

Regulatory issues in clinical applications of cytokines and growth factors

Riposte: FDA response to 'Yin, yang and the biopharmaceutical industry'

State and Local Chronic Disease Surveillance Using Electronic Health Record Systems

Mouse screen reveals multiple new genes underlying mouse and human hearing loss

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

Cryopyrin activates the inflammasome in response to toxins and ATP

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma

Suchergebnisse filtern